Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?

Published: 2026-08-26

Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?
Read full article

Originally sourced from Yahoo

Read the full story on Global Insight Daily